These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2460476)

  • 1. Activation of keratinocyte fibronectin receptor function during cutaneous wound healing.
    Grinnell F; Toda K; Takashima A
    J Cell Sci Suppl; 1987; 8():199-209. PubMed ID: 2460476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin receptors of human keratinocytes and their expression during cell culture.
    Toda K; Tuan TL; Brown PJ; Grinnell F
    J Cell Biol; 1987 Dec; 105(6 Pt 2):3097-104. PubMed ID: 2961770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human keratinocyte fibronectin receptor function in relation to other ligand-receptor interactions.
    Toda K; Grinnell F
    J Invest Dermatol; 1987 Apr; 88(4):412-7. PubMed ID: 2435816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of rabbit keratinocyte fibronectin receptor function in vivo during wound healing.
    Takashima A; Billingham RE; Grinnell F
    J Invest Dermatol; 1986 May; 86(5):585-90. PubMed ID: 2427619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of extracellular matrices on human keratinocyte adhesion and growth and on its secretion and deposition of fibronectin in culture.
    Kubo M; Kan M; Isemura M; Yamane I; Tagami H
    J Invest Dermatol; 1987 May; 88(5):594-601. PubMed ID: 2437213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin matrix deposition and fibronectin receptor expression in healing and normal skin.
    Clark RA
    J Invest Dermatol; 1990 Jun; 94(6 Suppl):128S-134S. PubMed ID: 2161886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of a BHK cell variant defective in the cell-substratum contact process.
    Shiba Y; Grinnell F
    J Cell Physiol; 1985 Dec; 125(3):449-55. PubMed ID: 2933417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Level of fibronectin mRNA is markedly increased in human chronic wounds.
    Ongenae KC; Phillips TJ; Park HY
    Dermatol Surg; 2000 May; 26(5):447-51. PubMed ID: 10816233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin-mediated keratinocyte migration and initiation of fibronectin receptor function in vitro.
    Takashima A; Grinnell F
    J Invest Dermatol; 1985 Oct; 85(4):304-8. PubMed ID: 2931488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human keratinocytes adhere to two distinct heparin-binding synthetic peptides derived from fibronectin.
    Wilke MS; Skubitz AP; Furcht LT; McCarthy JB
    J Invest Dermatol; 1991 Sep; 97(3):573-9. PubMed ID: 1875056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human keratinocyte adhesion and phagocytosis promoted by fibronectin.
    Takashima A; Grinnell F
    J Invest Dermatol; 1984 Nov; 83(5):352-8. PubMed ID: 6208292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical application of plasma fibronectin in full-thickness skin wound healing in rats.
    Kwon AH; Qiu Z; Hirao Y
    Exp Biol Med (Maywood); 2007 Jul; 232(7):935-41. PubMed ID: 17609510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesive responses of fibroblast and neuroblastoma cells to substrata coated with polyvalent or monoclonal antibody to fibronectin.
    Harrison DD; Culp LA
    Exp Cell Res; 1983 Jun; 146(1):29-42. PubMed ID: 6861909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibronectin precoating wound bed enhances the therapeutic effects of autologous epidermal basal cell suspension for full-thickness wounds by improving epidermal stem cells' utilization.
    Wang P; Hu Z; Cao X; Huang S; Dong Y; Cheng P; Xu H; Shu B; Xie J; Wu J; Tang B; Zhu J
    Stem Cell Res Ther; 2019 Sep; 10(1):154. PubMed ID: 31506090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous wound healing: a model for cell-matrix interactions.
    Woodley DT; O'Keefe EJ; Prunieras M
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 2):420-33. PubMed ID: 2579110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglioside GT1b inhibits keratinocyte adhesion and migration on a fibronectin matrix.
    Paller AS; Arnsmeier SL; Chen JD; Woodley DT
    J Invest Dermatol; 1995 Aug; 105(2):237-42. PubMed ID: 7636307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in keratinocyte adhesion during terminal differentiation: reduction in fibronectin binding precedes alpha 5 beta 1 integrin loss from the cell surface.
    Adams JC; Watt FM
    Cell; 1990 Oct; 63(2):425-35. PubMed ID: 2145076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin inhibits the terminal differentiation of human keratinocytes.
    Adams JC; Watt FM
    Nature; 1989 Jul; 340(6231):307-9. PubMed ID: 2473404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibronectin, as well as other extracellular matrix proteins, mediate human keratinocyte adherence.
    Clark RA; Folkvord JM; Wertz RL
    J Invest Dermatol; 1985 May; 84(5):378-83. PubMed ID: 2582060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of fibronectin-mediated cell migration: dependence or independence of cell migration susceptibility on RGDS-directed receptor (integrin).
    Straus AH; Carter WG; Wayner EA; Hakomori S
    Exp Cell Res; 1989 Jul; 183(1):126-39. PubMed ID: 2544438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.